Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1983 1
2001 1
2004 2
2006 2
2007 5
2008 5
2009 3
2010 5
2011 6
2012 8
2013 11
2014 7
2015 9
2016 14
2017 10
2018 12
2019 10
2020 12
2021 15
2022 15
2023 22
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade.
Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, Engle JW, Le T, Kim K, Bednarz B, Sondel PM, Weichert J, Morris ZS. Patel RB, et al. Among authors: erbe a. Sci Transl Med. 2021 Jul 14;13(602):eabb3631. doi: 10.1126/scitranslmed.abb3631. Sci Transl Med. 2021. PMID: 34261797 Free PMC article.
Ions and solvation at biointerfaces.
Valtiner M, Erbe A, Rosenhahn A. Valtiner M, et al. Among authors: erbe a. Biointerphases. 2016 Mar 11;11(1):018801. doi: 10.1116/1.4942207. Biointerphases. 2016. PMID: 26968212 No abstract available.
NK cells propagate T cell immunity following in situ tumor vaccination.
Jin WJ, Jagodinsky JC, Vera JM, Clark PA, Zuleger CL, Erbe AK, Ong IM, Le T, Tetreault K, Berg T, Rakhmilevich AL, Kim K, Newton MA, Albertini MR, Sondel PM, Morris ZS. Jin WJ, et al. Among authors: erbe ak. Cell Rep. 2023 Dec 26;42(12):113556. doi: 10.1016/j.celrep.2023.113556. Epub 2023 Dec 13. Cell Rep. 2023. PMID: 38096050 Free PMC article.
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies.
Pascual-Pasto G, McIntyre B, Shraim R, Buongervino SN, Erbe AK, Zhelev DV, Sadirova S, Giudice AM, Martinez D, Garcia-Gerique L, Dimitrov DS, Sondel PM, Bosse KR. Pascual-Pasto G, et al. Among authors: erbe ak. J Immunother Cancer. 2022 Dec;10(12):e004704. doi: 10.1136/jitc-2022-004704. J Immunother Cancer. 2022. PMID: 36460335 Free PMC article.
Roles of CD4+ T cells as mediators of antitumor immunity.
Kravtsov DS, Erbe AK, Sondel PM, Rakhmilevich AL. Kravtsov DS, et al. Among authors: erbe ak. Front Immunol. 2022 Sep 9;13:972021. doi: 10.3389/fimmu.2022.972021. eCollection 2022. Front Immunol. 2022. PMID: 36159781 Free PMC article. Review.
A Children's Health Perspective on Nano- and Microplastics.
Sripada K, Wierzbicka A, Abass K, Grimalt JO, Erbe A, Röllin HB, Weihe P, Díaz GJ, Singh RR, Visnes T, Rautio A, Odland JØ, Wagner M. Sripada K, et al. Among authors: erbe a. Environ Health Perspect. 2022 Jan;130(1):15001. doi: 10.1289/EHP9086. Epub 2022 Jan 26. Environ Health Perspect. 2022. PMID: 35080434 Free PMC article.
176 results